Pharmaceutical
Manufacturing
Europe

Endo

$8.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.07 (-0.84%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Endo and other stocks, options, ETFs, and crypto commission-free!

About

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. Read More The firm operates through the following segments: U.S. Branded-Specialty & Established Pharmaceuticals, U.S. Branded-Sterile Injectables, U.S. Generic Pharmaceuticals and International Pharmaceuticals. The U.S. Branded-Specialty & Established Pharmaceuticals segment offers prescription products to treat and manage conditions in urology, urologic oncology, endocrinology, pain and orthopedics. The U.S. Branded-Sterile Injectables segment consists primarily of branded sterile injectable products such as VASOSTRICT, ADRENALIN and APLISOL, among others, and certain generic sterile injectable products, including ertapenem for injection and ephedrine sulfate injection, among others. The U.S. Generic Pharmaceuticals segment consists of a differentiated product portfolio including solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmics and sprays and includes products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health and cardiovascular disease markets, among others. The International Pharmaceuticals segment includes a variety of pharmaceutical products for the Canadian, Latin American, South African, and world markets. The company was founded in 1997 and is headquartered Dublin, Ireland.

Employees
2,910
Headquarters
Dublin, Dublin
Founded
1997
Market Cap
1.87B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
4.72M
High Today
$8.39
Low Today
$8.09
Open Price
$8.36
Volume
667.42K
52 Week High
$18.50
52 Week Low
$5.27

Collections

Pharmaceutical
Manufacturing
Europe
Health
Europe (Non-UK)
Technology

News

MarketWatchMar 20

Endo International PLC

Stocks were indicated to open marginally higher on Wednesday ahead of the FOMC decision on interest rates. With the market having recouped so much ground in 2019, investors need to consider how they want their investments and assets positioned for the rest of 2019 and for the long haul. 24/7 Wall St. reviews dozens of [ ] Endo International PLC Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical produc...

95
Yahoo FinanceMar 19

Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Leading Peer-Reviewed Dermatology Journal Features Phase 2 Data DUBLIN, March 19, 2019 /PRNewswire/ -- Endo International plc (ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") for the treatment of cellulite in Dermatologic Surgery, the official journal of the American Society for Dermatologic Surgery. CCH is the first and only investigational injectable treatment designed specifically to reduce the appearance of cellulite by disrupting the col...

101
Seeking AlphaMar 15

Endo prices upsized tender offer for outstanding debt

Endo International (NASDAQ:ENDP) subsidiary Par Pharmaceutical has priced its $1.5B (from $1B) aggregate principal amount of 7.500% senior secured notes due 2027 at par.

68

Earnings

$0.54
$0.67
$0.80
$0.93
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.